15.07.2015
Test enzymatique sur bandelettes pour le dosage semi-quantitatif de l’H2O2
This is a case-ascertained prospective investigation of all identified health care contacts working in a health care facility in which a laboratory confirmed 2019-nCoV infected patient (see 2.2 Study population) receives care. Note that this study can be done in health care facilities at all 3 level...s of a health system – not just in hospitals. It is intended to provide epidemiological and serologic information which will inform the identification of risk factors 2019-nCoV infection among health care workers.
There are three primary objectives of this investigation among health care workers in a health care setting where a 2019-nCoV infected patient is being cared for:
To better understand the extent of human-to-human transmission among health care workers, by estimating the secondary infection rate1 for health care worker contacts at an individual level.
To characterize the range of clinical presentation of infection and the risk factors for infection among health care workers.
To evaluate effectiveness of infection prevention and control measures among health care workers
To evaluate effectiveness of infection prevention and control programmes at health facility and national level
more
The household transmission investigation is a case-ascertained prospective study of all identified household contacts of a laboratory confirmed 2019-nCoV infection (see 2.2 Study population). It is intended to provide rapid and early information on the clinical, epidemiological and virological chara...cteristics of 2019-nCoV.
There are three primary objectives of this household transmission study:
To better understand the extent of transmission within a household by estimating the secondary infection rate for household contacts at an individual level, and factors associated with any variation in the secondary infection risk.
To characterize secondary cases including the range of clinical presentation, risk factors for infection, and the extent and fraction of asymptomatic infections.
To characterize serologic response following confirmed 2019-nCoV infection (highly encouraged, but optional depending on laboratory capacity and resources)
more
Countries who have no testing capacity can send their samples to the WHO appointed 2019-nCoV referral laboratories for testing. National 2019-nCoV laboratories with limited experience are encouraged to send the first five positives and the first ten negative 2019-nCoV samples to their referral labor...atories for confirmation.
more
Les coronavirus sont une vaste famille de virus susceptibles de provoquer des maladies diverses chez l'homme, allant du simple rhume au syndrome respiratoire du Moyen-Orient (MERS) et au syndrome respiratoire aigu sévère (SRAS).
Un nouveau coronavirus (CoV) a été identifié en 2019 à Wuhan, ...en Chine. Il s'agit d'un nouveau coronavirus qui n'avait pas encore été identifié chez l'homme.
Ce cours constitue une introduction générale au nCoV et aux virus respiratoires émergents ; il est destiné aux professionnels de santé publique, aux gestionnaires d'incidents, coordonnateurs d’urgence et aux collaborateurs travaillant pour les Nations Unies, les organisations internationales, ainsi que les ONG.
more
Freiwilligenbörse zur Unterstützung der Gesundheitsämter bei der Bearbeitung der SARS-CoV-2-Infektionen.
Lifeology is a platform that brings together scientists, artists, writers and broader audiences in the creation of educational content including mobile-friendly Lifeology mini-courses that can reach anyone.
Groundbreaking science is increasingly collaborative and interdisciplinary. The same is tr...ue for science communication (or scicomm, as we like to call it). By working with artists and writers here at Lifeology.io, scientists can better communicate their work with relevance to society and people’s daily lives.
more
In this comic story, children will learn how the coronavirus works in the human body, and how the body can fight it!
1PEP GUIDELINES | 2019 EDITION. The prevalence of both HIV and Hepatitis B is high in South Africa therefore there is a significant risk of acquiring these infections following exposure to infected material. Studies suggest that post- exposure prophylaxis (PEP) with highly active antiretroviral trea...tment (HAART) is highly effective in preventing HIV infection if taken correctly for the full recommended duration of 28 days, and that prophylaxis with Hepatitis B immunoglobulin and vaccination may prevent Hepatitis B infection if given soon after exposure. This update of the Western Cape guidelines for management of potentially infectious exposures is based on current evidence and guidelines issued by the WHO, NDoH and the SA HIV Clinicians Society. The key aim is to promote successful completion of the recommended ART regimen in the 28 day period of therapy, as well as prevent infection with Hepatitis B
more
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Guidance for health care workers.
Both the REGN-EB3 and mAb114 are recommended for use in EVD. The two drugs should not be given together. The choice of which monoclonal antibody to use depends on availability, including emerging information about effectiveness.
Technical document, update 2021